Fecal Microbiota Transpant (FMT)
Inbiome performed a study on the impact of FMT in Irritable Bowel Syndrome (IBS) patients by using Molecular Culture® Microbiota. Results showed that the therapy effect on symptoms varies and depends on the specific donor. Moreover, by monitoring the composition of patients’ gut microbiota, inbiome was able to assess the engraftment of the transplant feces and link it to effects on wellbeing.
with Molecular Culture, the diagnosis was made faster than traditional culture and the patient could have been cured much sooner.